SCHEMBL6437449

SCHEMBL6437449

C=C(C)C(=O)CCOP(=O)([O-])OCC[N+](C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.55
LMNA P02545 2/20 0.51
ESR1 P03372 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
CDC25A P30304 1/20 0.51
AGTR1 P30556 1/20 0.51
AKT1 P31749 1/20 0.51
ADRA1A P35348 1/20 0.51
KCNH2 Q12809 1/20 0.51
ADRA1D P25100 1/20 0.45
PTAFR P25105 1/20 0.45
HTR1D P28221 1/20 0.45
HTR2C P28335 1/20 0.45
ADRA1B P35368 1/20 0.45
DRD3 P35462 1/20 0.45
TMEM97 Q5BJF2 1/20 0.45
MAPT P10636 2/20 0.44
PLA2G1B P04054 1/20 0.43
PLA2G2A P14555 1/20 0.43
NR5A2 O00482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1146679 0.87 BTN3A1 (0.44) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL35785 0.81 SMN1; SMN2 (0.49) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL20401677 0.81 SMN1; SMN2 (0.49) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL5476581 0.81 SMN1; SMN2 (0.49) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL3524266 0.81 SMN1; SMN2 (0.48) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL16026872 0.80 SMN1; SMN2 (0.44) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL3683081 0.79 SMN1; SMN2 (0.47) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL423161 0.79 LMNA (0.57) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL1261204 0.79 LMNA (0.54) SMN1; SMN2LMNAESR1ADORA3CDC25A
SCHEMBL15393542 0.79 SMN1; SMN2 (0.47) SMN1; SMN2LMNAESR1ADORA3CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3870660-B1 SILICONE MATERIAL WITH MODIFIED SURFACE TO IMPROVE SLIDING AND FRICTIONAL PROPERTIES BIOTRONIK SE & CO KG (DE) 2025-12-03 EP disclosed
CN-117123153-A Preparation method of fluorescent molecularly imprinted polymer microspheres suitable for complex water sample analysis 南开沧州渤海新区绿色化工研究有限公司 2023-11-28 CN disclosed
US-20210363474-A1 METHOD FOR PRODUCING CELL SHEET, CARDIOMYOCYTE SHEET, AND KIT FOR PRODUCING CARDIOMYOCYTE SHEET MYORIDGE CO. LTD. (JP) 2021-11-25 US disclosed
EP-3819373-A1 CELL SHEET MANUFACTURING METHOD, CARDIAC MUSCLE CELL SHEET, AND KIT FOR MANUFACTURING CARDIAC MUSCLE CELL SHEET Myoridge Co. Ltd. (JP) 2021-05-12 EP disclosed
WO-2020009188-A1 CELL SHEET MANUFACTURING METHOD, CARDIAC MUSCLE CELL SHEET, AND KIT FOR MANUFACTURING CARDIAC MUSCLE CELL SHEET 株式会社マイオリッジ 2020-01-09 WO disclosed
EP-1474719-A4 POLYMERIZATION PROCESS AND MATERIALS FOR BIOMEDICAL APPLICATIONS ZMS LLC (US) 2005-12-14 EP disclosed
US-20050090612-A1 Polymerization process and materials for biomedical applications ZMS, L.L.C.; A CALIFORNIA LIMITED LIABILITY CORPORATION 2005-04-28 US disclosed
US-20040266941-A1 Biomedical molding materials from semi-solid precursors ZMS, L.L.C. 2004-12-30 US disclosed
EP-1474719-A1 POLYMERIZATION PROCESS AND MATERIALS FOR BIOMEDICAL APPLICATIONS ZMS, LLC (US) 2004-11-10 EP disclosed
EP-1407297-A1 BIOMEDICAL MOLDING MATERIALS FROM SEMI-SOLID PRECURSORS ZMS, LLC (US) 2004-04-14 EP disclosed
WO-2003071339-A1 POLYMERIZATION PROCESS AND MATERIALS FOR BIOMEDICAL APPLICATIONS ZMS, LLC (US) 2003-08-28 WO disclosed
US-20030020870-A1 Biomedical molding materials from semi-solid precursors ZMS, LLC 2003-01-30 US disclosed
WO-2003003073-A1 BIOMEDICAL MOLDING MATERIALS FROM SEMI-SOLID PRECURSORS ZMS, LLC (US) 2003-01-09 WO disclosed
US-20020045706-A1 Biomedical molding materials from semi-solid precursors ZMS, LLC 2002-04-18 US disclosed